Reading the Evidence
Blinding Is Harder Than It Sounds and Often Fails
A double-blind trial is the standard everyone cites, and it is easier to declare than to achieve. Whether participants could guess their group is a question surprisingly few studies ask.
Most explanations of blinding in trials and how it breaks down stop at the point where it starts to matter. This one carries on.
The short version
- Side effects, taste and appearance all let participants guess their allocation.
- Unblinding matters most when the outcome is subjective.
- Few trials report whether participants correctly guessed their group.
What blinding is for
Blinding keeps participants, and ideally staff and assessors, unaware of which treatment each person received. Its purpose is to prevent expectation from influencing what people report and what assessors record.
It matters most for subjective outcomes such as pain, fatigue, mood and sleep quality, which are exactly the outcomes wellness products target. For a hard outcome such as death, blinding of the participant matters far less, though blinded assessment still helps. The value of blinding therefore depends on the outcome, which is a nuance the label double-blind conceals.
How participants work it out
A supplement with a distinctive taste, smell or colour is identifiable the first time it is taken. Side effects are the most reliable giveaway, since a substance producing flushing, tingling or bright urine announces itself.
Anything with a stimulant effect is essentially impossible to blind, because the participant can feel the difference within an hour. Devices and physical treatments are worse still, since nobody is uncertain about whether they received a massage. Once a participant believes they know their group, expectation is back in the trial regardless of what the protocol says.
What an active control does
A placebo designed to reproduce recognisable side effects makes guessing harder, and this is called an active placebo. Very few supplement trials use one, partly because it is difficult and partly because there is no incentive to.
Comparing against a placebo indistinguishable in every way except effect is the ideal and is often unattainable. Where blinding is impossible, blinded outcome assessment by someone unaware of allocation preserves part of the protection. Reporting honestly that blinding was not achieved is better science than asserting a blind that failed.
The test nobody runs
It is straightforward to ask participants at the end of a trial which group they believe they were in. If they guess correctly far more often than chance, the trial was not effectively blinded and its subjective outcomes are compromised.
This check is cheap, takes one question, and is reported in a small minority of trials. Its absence is not proof of a problem, and its presence is a strong signal that the researchers were being careful.
When you can find it, it is one of the most informative single lines in a paper.
Who else needs blinding
Clinicians who know the allocation may treat the two groups differently in small ways, including how they ask about symptoms. Assessors who know which group a participant is in score subjective measures differently, which has been demonstrated repeatedly. Statisticians analysing the data blinded to group labels are less likely to make choices that favour a hoped-for result.
Double-blind is used loosely and rarely specifies who exactly was blinded, which is why the methods section matters. The best papers state precisely who was blinded, how, and what was done to maintain it.
Where this bites hardest
Wellness research combines subjective outcomes, motivated participants, obvious interventions and small samples, which is the worst possible combination for blinding. Trials of devices, massage, diets and exercise programmes cannot blind participants at all, which is an honest limitation rather than a scandal.
Follow the mechanism and it means results from such trials should be read as including expectation effects, because they necessarily do. Comparing two active treatments against each other sidesteps some of this, since both groups expect benefit. Asking how a trial handled blinding is one of the quickest ways to judge how seriously the researchers took their own question.
The takeaway
Ask who was blinded and whether anyone checked. A stimulant, a strong taste or a massage cannot be hidden from the person receiving it.
When the marketing is more precise than the study, believe the study.
Questions readers ask
Can a diet trial be blinded?
Not for the participants, since people know what they are eating. Blinded outcome assessment and objective measurements are the available protections, and diet trials should be read with that limitation in mind.
Does a failed blind invalidate a trial?
Not automatically, and it weakens the subjective outcomes most. Objective measures such as blood tests and imaging are less affected, which is why they carry more weight in unblindable trials.
